InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by TURKEL CATHERINE C.. Officer active across 1 company, notably Lexaria Bioscience Corp.. Aggregated, 2 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €9k. Activity tracked since 9 February 2023. The latest transaction was filed on 12 August 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations